The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women with Rheumatoid Arthritis: A Double-Blind, Randomized Controlled Trial
Javadi F, Ahmadzadeh A, Eghtesadi S, Aryaeian N, Jazayeri S
Published in Journal of the American College of Nutrition
Methodology
Randomized, double-blind, placebo-controlled trial of 500 mg/day quercetin for 8 weeks in women with rheumatoid arthritis
Key Findings
Quercetin significantly reduced early morning stiffness, morning pain and after-activity pain, lowered DAS-28 and HAQ scores, and reduced plasma hs-TNF-alpha. Tender and swollen joint counts did not differ significantly between groups.
Conclusions
Quercetin improved clinical symptoms and disease activity in women with rheumatoid arthritis over 8 weeks.
Limitations
Single-centre, women only, small sample, short duration, objective joint counts unchanged.
Supplements Studied
Quercetin supplementation for 8 weeks significantly reduced EMS, morning pain, and after-activity pain
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.